Suppr超能文献

第三届人类和动物用生物制品中外源病毒经下一代测序检测会议报告。

Report of the third conference on next-generation sequencing for adventitious virus detection in biologics for humans and animals.

机构信息

Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.

European Directorate for the Quality of Medicines and Healthcare, Strasbourg, France.

出版信息

Biologicals. 2023 Aug;83:101696. doi: 10.1016/j.biologicals.2023.101696. Epub 2023 Jul 19.

Abstract

Next-generation sequencing (NGS) has been proven to address some of the limitations of the current testing methods for adventitious virus detection in biologics. The International Alliance for Biological Standardization (IABS), the U.S. Food and Drug Administration (FDA), and the European Directorate for the Quality of Medicines and Healthcare (EDQM) co-organized the "3rd Conference on Next-generation Sequencing for Adventitious Virus Detection in Biologics for Humans and Animals", which was held on September 27-28, 2022, in Rockville, Maryland, U.S.A. The meeting gathered international representatives from regulatory and public health authorities and other government agencies, industry, contract research organizations, and academia to present the current status of NGS applications and the progress on NGS standardization and validation for detection of viral adventitious agents in biologics, including human and animal vaccines, gene therapies, and biotherapeutics. Current regulatory expectations were discussed for developing a scientific consensus regarding using NGS for detection of adventitious viruses. Although there are ongoing improvements in the NGS workflow, the development of reference materials for facilitating method qualification and validation support the current use of NGS for adventitious virus detection.

摘要

下一代测序(NGS)已被证明可以解决当前生物制品中偶然病毒检测方法的一些局限性。国际生物标准化联盟(IABS)、美国食品和药物管理局(FDA)和欧洲药品质量管理局(EDQM)共同组织了“第三届人类和动物用生物制品中偶然病毒检测的下一代测序会议”,该会议于 2022 年 9 月 27 日至 28 日在美国马里兰州罗克维尔举行。会议聚集了来自监管和公共卫生当局以及其他政府机构、行业、合同研究组织和学术界的国际代表,介绍了 NGS 应用的现状以及 NGS 标准化和验证的进展,用于检测生物制品中的病毒外来剂,包括人类和动物疫苗、基因治疗和生物治疗药物。讨论了制定使用 NGS 检测偶然病毒的科学共识的当前监管期望。尽管 NGS 工作流程正在不断改进,但参考材料的开发有助于方法资格和验证,支持当前 NGS 用于偶然病毒检测。

相似文献

1
Report of the third conference on next-generation sequencing for adventitious virus detection in biologics for humans and animals.
Biologicals. 2023 Aug;83:101696. doi: 10.1016/j.biologicals.2023.101696. Epub 2023 Jul 19.
3
IABS/DCVMN webinar on next generation sequencing.
Biologicals. 2023 Feb;81:101662. doi: 10.1016/j.biologicals.2022.12.001. Epub 2022 Dec 19.
5
Report of the international conference on next generation sequencing for adventitious virus detection in biologicals.
Biologicals. 2018 Sep;55:1-16. doi: 10.1016/j.biologicals.2018.08.002. Epub 2018 Aug 6.
6
Validation of a Next Generation Sequencing Method for adventitious agents detection in a live vaccine matrix.
Biologicals. 2025 May;90:101828. doi: 10.1016/j.biologicals.2025.101828. Epub 2025 Apr 2.
8
Historical evaluation of the in vivo adventitious virus test and its potential for replacement with next generation sequencing (NGS).
Biologicals. 2023 Feb;81:101661. doi: 10.1016/j.biologicals.2022.11.003. Epub 2023 Jan 6.
10
Proceedings of the 2019 Viral Clearance Symposium, Session 7: Cell Banks and U.S. Pharmacopeia.
PDA J Pharm Sci Technol. 2022 Jul-Aug;76(4):358-361. doi: 10.5731/pdajpst.2021.012683. Epub 2021 Dec 15.

引用本文的文献

1
A sensitive sample preparation pipeline for adventitious virus detection using Oxford Nanopore sequencing.
Mol Ther Methods Clin Dev. 2025 Apr 24;33(2):101478. doi: 10.1016/j.omtm.2025.101478. eCollection 2025 Jun 12.
2
Next-generation sequencing: A powerful multi-purpose tool in cell line development for biologics production.
Comput Struct Biotechnol J. 2025 Apr 3;27:1511-1517. doi: 10.1016/j.csbj.2025.04.006. eCollection 2025.
3
Virus detection by short read high throughput sequencing in a high virus low cellular background.
NPJ Vaccines. 2025 Mar 29;10(1):61. doi: 10.1038/s41541-025-01104-1.
4
High-throughput sequencing as a potential tool in the quality control of infectious bronchitis vaccines.
J Vet Res. 2024 Dec 21;68(4):475-485. doi: 10.2478/jvetres-2024-0069. eCollection 2024 Dec.

本文引用的文献

1
IABS/DCVMN webinar on next generation sequencing.
Biologicals. 2023 Feb;81:101662. doi: 10.1016/j.biologicals.2022.12.001. Epub 2022 Dec 19.
4
long-read-tools.org: an interactive catalogue of analysis methods for long-read sequencing data.
Gigascience. 2021 Feb 16;10(2). doi: 10.1093/gigascience/giab003.
5
VirSorter2: a multi-classifier, expert-guided approach to detect diverse DNA and RNA viruses.
Microbiome. 2021 Feb 1;9(1):37. doi: 10.1186/s40168-020-00990-y.
6
Metagenomic characterization of parental and production CHO cell lines for detection of adventitious viruses.
Biologicals. 2021 Jan;69:70-75. doi: 10.1016/j.biologicals.2020.11.001. Epub 2020 Nov 24.
7
RVDB-prot, a reference viral protein database and its HMM profiles.
F1000Res. 2019 Apr 23;8:530. doi: 10.12688/f1000research.18776.2. eCollection 2019.
8
Sensitivity and breadth of detection of high-throughput sequencing for adventitious virus detection.
NPJ Vaccines. 2020 Jul 17;5(1):61. doi: 10.1038/s41541-020-0207-4. eCollection 2020.
10
Viral contamination in biologic manufacture and implications for emerging therapies.
Nat Biotechnol. 2020 May;38(5):563-572. doi: 10.1038/s41587-020-0507-2. Epub 2020 Apr 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验